News

1 to 9 of 11 results

Daiichi Sankyo's Azor improves 24-hour ABP

12-05-2009

Japanese drugmaker Daiichi Sankyo reported data at the 2009 annual meeting of the American Society of…

Amlodipine and Olmesartan Medoxomil TabletsAmlodipine BesylateAzorBenicarDaiichi SankyoNorvascolmesartanSankyo

Mylan sued by Daiichi Sankyo over Azor patent

09-06-2008

US generics major Mylan says that its majority-owned subsidiary, Matrix Laboratories, is being sued by…

Amlodipine and Olmesartan Medoxomil TabletsAmlodipine BesylateAzorBenicarDaiichi SankyoNorvascolmesartanSankyo

Daiichi Sankyo streamlining leads to fall in revenue but 24% increase in profit

26-05-2008

Japanese drugmaker Daiichi Sankyo has reported a 5% drop in revenue for the fiscal year ended March 31,…

Amlodipine and Olmesartan Medoxomil TabletsAmlodipine BesylateAzorBenicarCarvedilolColesevelam HclCoregDaiichi SankyoIron Sucrose InjectionLevaquinLevofloxacinNorvascolmesartanSankyoVenoferWelchol

Forest takes $44M hit on ending Azor deal

19-05-2008

US drugmaker Forest Laboratories and the local unit of Japan's Daiichi Sankyo have terminated their co-promotion…

Amlodipine and Olmesartan Medoxomil TabletsAzorBenicarBenicar HCTDaiichi SankyoForest LaboratoriesolmesartanOlmesartan Medoxomil-HydrochlorothiazideSankyo

Daiichi Sankyo and Forest finalize Azor co-promotion deal

22-10-2007

The US subsidiary of Japan's Daiichi Sankyo and Forest Laboratories say that they have signed a contract…

Amlodipine and Olmesartan Medoxomil TabletsAzorBenicarDaiichi SankyoForest LaboratoriesolmesartanSankyo

Japan stock market week to September 3, 2007

10-09-2007

Tokyo rebounded moderately in the week ended September 3. The Nikkei 225 gained 1.4% to recover the 16,500…

Amlodipine and Olmesartan Medoxomil TabletsAriceptAtacandAzorBenicarCandesartan CilexetilDaiichi SankyodonepezilEisaiForest LaboratoriesHumulin 70-30Humulin NHumulin RInsulinIpsenLillyolmesartanPfizerRocheSankyo

1 to 9 of 11 results

COMPANY SPOTLIGHT

Menarini

Back to top